BEAM vs BXP · rev $63.5M vs rev $3.48B
Beam Therapeutics Inc (BEAM) versus Boston Properties Inc (BXP) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
BEAM currently screens at market cap $2.01B. BXP currently screens at market cap $12.12B.
Not investment advice. Open the BEAM and BXP stock pages for the full models.
Not investment advice.